Skip to main content
Download PDF
  • Research article
  • Open access
  • Published:

Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin

BMC Public Health volume 20, Article number: 1267 (2020) Cite this article

Abstract

Background

In Benin, men who have sex with men (MSM) do not always use condoms during anal sex. Pre-exposure prophylaxis (PrEP) using Truvada® (tenofovir disoproxil fumarate / emtricitabine) may be a complementary HIV prevention measure for MSM. This study aimed at identifying the potential facilitators and barriers to the use of PrEP.

Methods

This was a cross-sectional study conducted in 2018 among male-born MSM aged 18 years or older who reported being HIV-negative or unaware of their HIV status. The participants were recruited by the RDS technique (respondent driven sampling) in six cities of Benin. Logistic regression analyses, adapted to RDS statistical requirements, were performed to identify the factors associated with PrEP acceptability.

Results

Mean age of the 400 MSM recruited was 26.2 ± 5.0 years. PrEP was known by 50.7% of respondents. The intention to use PrEP was expressed by 90% of MSM. If PrEP effectiveness were 90% or more, 87.8% of the respondents thought they would decrease condom use. In multivariate analysis, the facilitators associated with PrEP acceptability were: not having to pay for PrEP (odds ratio (OR) = 2.39, 95% CI: 1.50–4.46) and its accessibility within MSM networks (OR = 9.82, 95% CI: 3.50–27.52). Only one barrier was significant: the concern that taking PrEP be perceived as marker of adopting HIV risky behaviors (OR = 0.11, 95% CI: 0.04–0.30).

Conclusion

In Benin, not all MSM know about PrEP. But once well informed, the majority seems willing to use it if made available. The free availability of the drug and its accessibility in the MSM networks are important facilitators. The possibility of decrease in condom use should not be a barrier to the prescription of PrEP if made available.

Peer Review reports

Background

In sub-Saharan Africa, the prevalence of HIV infection among MSM significantly higher among MSM than in the general population [1]. One of the reasons for the high prevalence among MSM may be that anal transmission of HIV without a condom is easier than vaginal transmission without a condom, and individual risks of HIV infection among MSM include unprotected passive anal sex, a high number of male partners, and concurrent injection drug use [2,3,4].

In Benin, HIV prevalence was estimated at 7.0% among MSM in 2014 [5], compared to 1% [0.7–1.7] in the general population [6]. As observed in other African countries [7], MSM in Benin are known to be difficult to access because they live in hiding due to the extent of stigma and discrimination against them. They have less access to curative and preventive care services. Behavioural prevention measures (regular condom use, abstinence, fidelity and testing) have also shown their limitations. For instance, only 33% of MSM in Benin report having used condoms all the time with all their partners in the last 6 months [5]. In this context of high risk of HIV infection due to the limited means of behavioural prevention, PrEP, integrated to combination prevention programmes, could prove useful in reducing the risk of transmission [8].

PrEP is an oral pill taken daily or on demand to reduce the risk of contracting HIV [9]. According to studies, it reduces HIV acquisition among MSM by 44 to 86% [10,11,12]. Based on scientific evidence regarding the acceptability of PrEP [13], its cost and feasibility, the World Health Organization (WHO) has expanded its 2014 recommendations to support PrEP supply to all populations at higher risk of HIV [14]. However, PrEP is not yet available for any population in Benin, including MSM. In addition, the scope of PrEP implementation, where available through different programs, appears to depend on its acceptability, the level of knowledge of MSM on this prevention method, as well as on various factors that could influence its use and its impact on risky sexual behaviors. PrEP acceptability varies across studies, with complex reasons in relation to the individual, the provider, the community and the health system [15]. Nearly half of the Nigerian MSM participants in one study had no prior knowledge of PrEP, but after being informed of its potential benefits, 80% were willing to use it [16]. In Kenya, it was found that 64.3% of participants had heard of PrEP and only half were willing to use it [17]. Several barriers were described by authors, such as stigma, cost, frequency of HIV counselling and treatment and possible drug interactions; concerns included the possible abandonment of condoms, increased risk of sexually transmitted infections, and non-compliance with medications and schedules, which need to be taken into account when setting up a PrEP programme [18].

This study aimed to assess PrEP knowledge and acceptability, to identify socio-demographic and behavioral variables associated with these two outcomes, as well as facilitators and barriers, associated with its acceptability in order to gather useful information for the PrEP programme in Benin prior to its implementation.

Methods

Participants and procedures

This study focused on men who identify themselves as MSM. Male-born participants, aged 18 years or older, self-reported as being HIV-negative or unaware of their HIV status, who reported at least one anal sex episode with a male partner in the last 12 months, were eligible for participation in this study.

The respondent driven sampling (RDS) technique [19], suitable for this type of population (MSM, hidden population), was used for the recruitment of participants in Benin cities with high concentration of MSM [20] such as Cotonou, Porto Novo, Abomey-Calavi, Pobe, Parakou and Bohicon. The RDS technique uses a referral chain (snowball) methodology for data collection from hard-to-reach populations whose members form linked social networks. RDS starts with a group of participants or “seeds” selected non-randomly from the target population. With the use of appropriate weights, the final sample obtained through RDS can be considered as representative of the target population [19].

In this study, seven seeds were distributed as follows: 2 in Cotonou and 1 in each of the 5 remaining cities. These seven initial seeds were chosen in consultation with the heads of MSM networks and associations in the country so that the seeds would have different characteristics and a large network of friends. After having given written informed consent, the seven seeds participated in the study. Afterward, each of them received five coupons to recruit, each, five MSM who were interested in the study. The new recruits, after having provided their informed consent, were also submitted to the questionnaires and then each received five coupons that allowed them to recruit five new MSM each and so on until the expected number of MSM was reached, our target being of 400 participants.

Questionnaire

The questionnaire was designed in conjunction with literature data and the results of a preliminary qualitative study on PrEP acceptability among MSM in Benin [21]. The qualitative study served as a springboard to contextualize the quantitative questionnaire used for the present study. This quantitative questionnaire included four sections: size of the personal network; socio-demographic characteristics; HIV-related characteristics and risks; and questions related to PrEP. It was administered through face-to-face interviews by trained investigators using a collection form that was filled in as it was administered. The questionnaire was administered in French and translated into local languages as appropriate. Fixed points were identified in the different cities to which the participants were directed to meet the data collector.

Measures

Prior to data collection, the questionnaire was pre-tested for understanding with 10 MSM who did not participate in the study afterwards. However, we did not assess test-retest reliability. In addition, since none of the construct used to measure facilitators and barrier to PrEP use included more than one item, the assessment of internal consistency was not applicable. Nearly all the variables described below were extracted from the literature on PrEP acceptability among MSM [22,23,24], with some variables coming from the qualitative study conducted beforehand [21].

PrEP knowledge

It was measured by asking participants if they had ever heard of PrEP (yes, no, uncertain). If yes, participants specified the channel through which they had heard about PrEP. Before carrying on with the rest of the questionnaire, we provided the following information about PrEP to all participants: “Pre-exposure prophylaxis (or PrEP) is an HIV prevention method that involves that people without HIV infection take a combination of two antiretroviral drugs in a single pill, also used to treat HIV, on a daily or on demand basis. PrEP is already used in several countries. This HIV prevention method involves uninfected but high-risk people, such as many men who have sex with men. PrEP users take this therapy in anticipation of potential exposure to HIV in order to reduce the risk of infection. Like “birth control pills“ for the prevention of pregnancies, PrEP could therefore be an attractive additional option for at-risk populations”.

PrEP acceptability

It was defined as the intention to use PrEP. Intention represents the motivation or the will to achieve behavior and is defined as the perception of the probability of adopting a behavior [25]. It has been measured in various ways in the literature, with their own limitations and advantages [23, 26,27,28]. For this study, a five-point Likert scale ranging from 5 (very likely) to 1 (unlikely) was used. Participants answered the following question: “If PrEP was available in Benin for the prevention of HIV infection, would you intend to use it as a HIV prevention method? ».

Preference of the desired mode of using PrEP

Participants were successively asked questions about the likelihood for them to use PrEP daily, every 3 days, weekly or on demand. Responses were expressed on a 5-point Likert scale of 5 (very likely) to 1 (not likely). Then they were asked their preference between the daily and the on-demand PrEP use.

Socio-demographic data

They included: age (years), marital status (married, single, widowed, cohabiting, no answer), education level (out of school, primary, secondary, higher), occupation (pupils or students, salaried employees, artisans or traders, unemployed, others to be specified); religion (traditional, Christian, Muslim, no religion, other), nationality (Beninese, others to be specified), member of an association of MSM (yes, no).

Sexual characteristics

They included: sexual orientation (homosexual, bisexual, heterosexual), active or insertive sexual role (during the sexual intercourse, who penetrates for anal sex, for oral sex), passive or receptive (during the sexual intercourse, who is penetrated for anal sex, for oral sex), versatile (which changes easily sex role in a sexual relationship, is sometimes insertive, sometimes receptive).

HIV risk perception

On a 5-point Likert scale ranging from 5 (very high) to 1 (not high at all), participants answered the following question: “Referring to your past and present sexual practices, at which level do you rank your risk of contracting HIV?”

Sexual behaviors during the last 6 months

These variables included: number of male sexual partners, sex outside the regular relationship, number of unprotected insertive and receptive sexual acts, condom use at last sex with a man, frequency of anal intercourse during the last 6 months; sexual relations after consumption of drugs or alcohol, sex in exchange for money or gifts, number of female partners, condom use during last sexual intercourse with a woman.

Facilitators and barriers to PrEP use

Facilitators and obstacles were identified in the literature [24], and then supplemented by other factors identified in the qualitative study carried out prior to this quantitative study [21].

The following question was asked: How important do you consider the following statements to be as facilitators or barriers to the use of PrEP? (1 = not at all important, 2 = not important, 3 = neutral, 4 = important, 5 = very important).

The facilitators used in this study were: 1. not having to pay for PrEP, 2. access to free HIV testing, 3. access to free health care/sexual monitoring, 4. access to individual support and support around the use of PrEP, 5. access to information on the use of PrEP, 6. access to support or counseling on my sex life, 7. not having to go to the casual doctor for the PrEP, 8. access to group membership information on PrEP use, 9. drug availability, 10. drug accessibility at the level of MSM network, 11. self-protection concern, 12. possibility of multiple partnerships, 13. lack of constraints during drug procurement, 14. sex possibilities with HIV-Positive.

The barriers used were: 1. concerns about PrEP long-term effects on my health, 2. concern about the fact that if I become infected by HIV, some ARV will no longer be efficient because they would have been taken as PrEP, 3. concern about the fact that PrEP does not provide a complete protection against HIV, 4. taking a drug every day, 5. concern that taking PrEP could make me more likely to have sex without condom, 6. concerns that having to take PrEP means that I put myself at risk for HIV, 7. PrEP could make my partners expect to have anal sex without condom with me, 8. concerns that people will see me taking medication and think I have HIV, 9. concerns that people will see me taking drug and will want to know why I’m taking it, 10. having to talk to my doctor about my sex life, 11. binding procedures for the drug procurement, 12. size and taste of the medication, 13. fee-paying drug, 14. concern that PrEP may lead to prostitution, 15. concern that PrEP might encourage to be unfaithful, 16. partner’s disagreement because I’m taking PrEP, 17. unreceptive attitude of the MSM community towards PrEP, 18. PrEP as source of discrimination in health centers, 19. concern that PrEP may increase risk-taking (e.g., increase in the number of unprotected sex acts, increase in the number of sexual partners, etc.), 20. concern that PrEP may increase the risk of contracting sexually transmitted infections other than HIV.

Risk behaviors under PrEP

On a five-point Likert scale ranging from 5 (definitely increase) to 1 (definitely decrease), participants answered the following three questions: according to you, how could PrEP use with a 90% effectiveness affect your frequency of condom use during anal sex? According to you, how could the use of PrEP with 90% effectiveness affect the number of your male sexual partners? According to you, how could the use of PrEP with 90% effectiveness affect the number of your anal intercourses?

Data processing

Data were entered into an EPI Data Version 3.1 database [29]. The variables measured on the Likert scale were dichotomized depending on their distribution across the five categories. Conceptually, categorization (4 + 5) versus (1 + 2 + 3) for the dependent variable (acceptability) is preferred. However, it was decided to use (5) versus (1 + 2 + 3 + 4) because there were not enough participants with (1 + 2 + 3). Different categorizations of the independent variables were tried. The categorization (4 + 5) versus (1 + 2 + 3) was chosen when possible (8 variables are categorized as (5) versus (1 + 2 + 3 + 4)). This seemed preferable from a conceptual point of view, as it provided reasonable « n » for the categories and logical results. Variables with low effective frequencies in categories 3, 2, and 1 were dichotomized as 5 versus 4 + 3 + 2 + 1. This includes the dependent variable (acceptability) and the following potential facilitators: not having to pay for PrEP, access to free HIV testing, access to free health care / sexual surveillance, access to personal coaching and support around the use of PrEP, access to information on the use of PrEP, access to support or counseling about one’s sex life, availability of the drug, accessibility of the drug at MSM level. The other variables measured on a Likert scale were dichotomized as 5 + 4 versus 3 + 2 + 1.

Statistical analysis

Data analysis used the RDS Analyst statistical software, version 0.65 [30] and SAS, version 9.4 (SAS Institute Inc., Cary, NC, USA). The RDS Analyst software was used to generate probability weights for each observation that were used in both the univariate and multivariate analyses with SAS. RDS-II weights calculated from the participant’s network size were used in order to address the potential biases introduced by chain recruitment [31]. Some extreme values were reported by the participants ​​ for the network sizes. To overcome this problem, we used an approach proposed by the RDS Analyst statistical software [32], which consists in calculating the weights with truncated network sizes. All network sizes above the 95th percentile were reduced to the 95th percentile (all sizes ≥110 were reduced to 110). And all network sizes below the 5th percentile were adjusted to the 5th percentile value (all sizes ≤4 were adjusted to 4).

Continuous variables were expressed in means with their standard deviation or medians with their interquartile ranges. Logistic regression was used to identify factors associated with knowledge and PrEP acceptability [33]. For knowledge of PrEP, the multivariate model was developed with the socio-demographic and behavioral variables selected from the univariate analysis at a threshold of p < 0.20. For PrEP acceptability, a first multivariate model was developed with the facilitators and barriers variables selected from the univariate analysis at a threshold of p < 0.20. A descending manual procedure was used to obtain an intermediate model at a threshold of p < 0.05. The socio-demographic and behavioral variables retained in the univariate analysis at a threshold of p < 0.20 were then added to this intermediate model. A new descending manual procedure was then performed in order to achieve the final model at a threshold of p < 0.05. The SAS survey logistic procedure was used for these univariate and multivariate analyses. The truncated weights generated by RDS Analyst served as the probability weights [34] and seeds were used as clusters to take into account homophily (the tendency to recruit later participants with the same characteristics as the initial ones). The adjusted odds ratios (OR) and their 95% confidence intervals (95%CI) were calculated.

Results

A total of 400 MSM were interviewed in the six cities covered by the study. Figure 1 presents the recruitment chain for each of the seven seeds.

Fig. 1
figure 1

Graphical representation of the recruitment generated by RDS Analyst (7 seeds), Benin, 2017–2018

Full size image

The population consisted of young people [mean age (standard deviation) 26.2 (5.0) years], mostly single (85.5%) with at a least secondary educational level (90.5%) and of Christian religion (57.7%). Those with a homosexual orientation accounted for 64% of the population, the rest of the participants reporting being bisexual. Sex roles in homosexual relationships were active (39.7%), passive (39.7%) or versatile (20.5%). Participants had sex with an average number of four different men in the last 6 months preceding the survey. Condom use at last sex was reported by 76.8% of the participants. Some of the surveyed MSM reported sex in exchange for money or gifts (24.5%).

PrEP was known to 50.7% of respondents before this study. Table 1 shows the univariate and multivariate analyses of the associations between participants’ characteristics and PrEP knowledge. In multivariate analysis, knowledge of PrEP was positively associated with advanced level of education (OR = 9.17, 95%CI: 2.41–34.88) and being married compared to being single (OR = 3.91, 95%CI: 1.12–13.61). Factors negatively associated with PrEP knowledge were: married status (OR = 0.25, 95%CI: 0.07–0.88); common-law union (OR = 0.12, 95%CI: 0.02–0.66); sexual intercourse after drug or alcohol use in the last 6 months (OR = 0.36, 95%CI: 0.22–0.60); and condom use at last sexual intercourse with a woman (OR = 0.44, 95%CI: 0.28–0.68).

Table 1 Characteristics of the MSM population and their associations with knowledge of PrEP, Benin
Full size table

The participants mostly preferred using it on a daily basis (69.2%). If PrEP effectiveness were 90%, most respondents thought they would decrease condom use (87.8%), increase the number of male sexual partners (69.0%), and increase the number of anal sex acts (74.2%). Nine out of ten MSM expressed a high intention (Likert 4 + 5) to use PrEP, including (35.8%) with a very high intention (Likert 5). The average (± standard deviation) of the Likert scale on the intention to use PrEP was 4.2 (± 0.8).

In univariate analysis, as shown in Table 2, acceptability was associated with age group 20–24 compared to < 20 (OR = 3.3, 95%CI: 1.12–9.80), with divorced and / or widowed status compared to married (OR = 17.4, 95%CI: 2.01–149.91), and with bisexual compared to homosexual orientation (OR = 2.8, 95%CI: 1.74–4.64).

Table 2 Characteristics of the MSM population and their association with PrEP acceptability, Benin
Full size table

PrEP’s acceptability facilitators identified during the univariate analysis are shown in Table 3. Most facilitators were perceived as important with almost all averages > 4. However, few barriers were perceived as important with average > 4. The facilitators significantly associated (OR > 1) with a high PrEP acceptability included: not having to pay for PrEP (OR = 9.45, 95%CI: 3.36–26.62), access to free HIV test (OR = 7.19, 95%CI: 2.90–17.81), Access to free healthcare/sexual life supervision (OR = 5.13, 95%CI: 2.24–11.73); Access to individual support and support around the use of PrEP (OR = 7.04, 95%CI: 2.65–18.67); Access to information on the use of PrEP (OR = 4.65, 95%CI: 1.32–16.37); Access to support or counseling about my sexual life (OR = 4.41, 95%CI: 1.80–10.79); PrEP drug availability (OR = 9.97, 95%CI: 1.73–57.32), PrEP drug accessibility at the level of MSM networks (OR = 15.14, 95%CI: 3.89–58.95), sex opportunity with HIV-positive people (OR = 2.09, 95%CI: 1.05–4.16). Barriers identified as significantly associated with acceptability of PrEP (OR < 1) were: the concern that “using PrEP means that I put myself at risk for HIV” (OR = 0.16, 95%CI: 0.06–0.41); the concern that “people will see me taking medication and think that I have HIV” (OR = 0.33, 95%CI: 0.14–0.77), restrictive procedures for drug procurement (OR = 0.34, 95%CI: 0.12–0.93); as well as pill’s size and taste (OR = 0.32, 95%CI: 0.11–0.91).

Table 3 Univariate analysis of PrEP acceptability according to facilitators and obstacles, Benin
Full size table

In the multivariate analysis presented in Table 4, the facilitators remaining significantly associated with PrEP acceptability were: not having to pay for PrEP (OR = 2.59, 95%CI: 1.50–4.46), access to personal support and support around the use of PrEP (OR = 4.35, 95%CI: 3.26–5.80), drug accessibility at the level of MSM networks (OR = 9.82, 95%CI: 3.50–27.52). One barrier proved to be significant: the concern that “taking PrEP means that one puts himself at risk for HIV” (OR = 0.11, 95%CI: 0.04–0.30). Other associated factors were: age 20–34 years (OR = 24.50, 95%CI: 4.13–145.24), in comparison with < 20 years (OR = 6.23, 95%CI: 1.49–26.52); and divorced and / or widowed status (OR = 103, 95%CI: 22.69–469.86).

Table 4 Multivariate Analysis of PrEP acceptability according to MSM characteristics, facilitators and obstacles, Benin
Full size table

Discussion

Most of the MSM surveyed lived in Cotonou, the economic capital of Benin. In general, MSM were young adults, christians, single people with a good level of education, most of them exclusively homosexual. They mostly preferred daily PrEP (vs. PrEP on demand). They estimated that their HIV-related individual risk was not high. About half of them had knowledge about PrEP, but once well informed, most of them were willing to use it if made available in Benin. Young adults, as well as those divorced and / or widowed were more likely to use it. Factors that could ease this use were: not having to pay for PrEP, access to individual support and support around the use of PrEP, and drug availability within the MSM networks.

PrEP could lead to the reduction or even the abandonment of traditional HIV prevention methods with an increasing risk of HIV, as most of those who were willing to use PrEP also considered reducing their use of condoms, or even expanding the number of sexual partners.

These results have a lot of similarities with those observed in other contexts. On this same issue, other studies conducted in low- and middle-income countries [35,36,37] also described relatively young educated subjects, mostly homosexual who were willing to use PrEP. The level of PrEP knowledge and associated factors seems to vary by context. The level of PrEP knowledge among our participants was quite high and appeared to be similar to what was observed in Nigeria and Kenya [16, 17]. It is not always high in developing countries [38]. In one Indian cohort, none of the focus group participants had heard of the term “PrEP”, nor were they aware that antiretroviral treatment could be used to prevent HIV infection [39]. It was found that despite the low level of PrEP awareness, MSM in low-income countries are willing to use it if they are appropriately supported to address a range of individual, social, and structural barriers [38].

The acceptability level of PrEP that we found was quite high even though respondents were unfamiliar with this prevention strategy. It should be noted that at the beginning of each questionnaire administration, an accurate information note was read and explained to the participants. This measure made it possible for them not to have to decide on a strategy on which they did not have enough information. From this point of view, we can say that the level of acceptability obtained reflects the reality of MSM’s intention to use PrEP if made available.

PrEP acceptability level varies across countries and for various reasons: In Nigeria, 53.6% of MSM were aware of PrEP and 80.1% were willing to use PrEP in Nigeria [16]. In Kenya, 64.3% who had heard of PrEP but only 50% were willing to use it. And condom use with regular partners, improved self-efficacy in condom use, better perception of ability to use PrEP, history of STIs and membership of an LGBT organization were significantly associated with knowledge of PrEP [17].

In some studies on the intention to use PrEP, a high level of PrEP acceptability was sometimes related to the intention to enhance risky sexual behaviors, such as stopping condom use and increasing the number of unprotected sexual contacts [40,41,42,43]. No PrEP studies in non-MSM individuals, including heterosexual people of the general population and sex workers, have shown an increase in risky behaviors under PrEP [44,45,46].

Factors that could affect the acceptability of PrEP were also found by others [13, 15, 24]. Attributing a financial cost to PrEP will affect observance and therefore the expected efficiency [23]. Similarly, the medication accessibility at the MSM network level would be an asset in the adoption of PrEP. The use of the drug would be easier because the fear of stigmatization would be reduced. PrEP programs will need to rely on HIV health and care services designed for key populations so as to reduce stigma and facilitate entry and clients retention [47]. The concern that taking PrEP means that a MSM puts himself at risk for HIV was found to be an obstacle to PrEP use. Taking PrEP may encourage more risky behavior. This is described in several papers [48,49,50,51]. Sexual behavior has been assessed by some authors by collecting information on: the number of male sexual partners, sex outside the main relationship, frequency of unprotected insertive and receptive sex, condom use at last sex, anal sex with both primary and occasional partners [52]. It would be unfortunate to lose all the benefits made in adopting good prevention practices at the expense of PrEP use. Strategies to help PrEP users recognize the types of risk associated with the situation and adopt appropriate prevention practices, such as limiting the number of sexual partners and the availability of condoms, can be a valuable complement for advising on PrEP therapeutic adherence [53]. However, this issue needs further discussion because the use of PrEP has not always led to higher rates of HIV or STI acquisition [54]. Significant differences have not always been demonstrated in the incidence of STIs among MSM PrEP users, compared to non-users [55]. Regular monitoring of MSM users of PrEP will allow to treat their STIs quickly, which could even lead, in the long run, to a reduction in STIs [56]. PrEP prescribers have an important role to play in testing and treating STIs as the incidence may increase if PrEP is administered without these services [57].

Other factors associated with PrEP acceptability were age of the MSM and their marital status. In the present study, PrEP acceptability was higher in men aged 25–34 years compared the oldest and youngest age groups. Although only a small proportion of men was aged < 20, the use of this group as the reference category allowed to detect this interesting association. The relationship between age and the acceptability of PrEP is variously discussed in the literature. Some studies confirm this relationship [58,59,60]. Others describe acceptability as higher among young MSM reporting risky sexual behaviors [61,62,63]. Few studies have found a significant relationship between age and the acceptability of PrEP [64]. With respect to marital status, the strength of the association between divorced / widowed marital status and PrEP acceptability was quite high, mainly due to the small size in this group and to a lesser extent to the use of odds ratios instead of prevalence ratios.

Previous studies on MSM in Benin focused on describing their characteristics as well as HIV prevalence and incidence in that community [5, 65]. Our study is the first to address the issue of PrEP among MSM in Benin and one of the first in West Africa [66]. The recruitment technique used is recognized as adequate for collecting reliable data among hidden populations such as MSM. Potential biases that could be introduced by this technique were taken into account by fitting the data to probability weights generated according to the requirements of the RDS method [31].

Limits of this study lie in the possibility of social desirability bias and non-representativeness of the entire MSM community in Benin, even though the study was held in six large cities throughout the country. Social desirability biases may come from the fairly sensitive questions asked during face-to-face interviews with participants. Non-representativeness is mentioned because only cities with high concentration of MSM (and only those who come out), have been selected for this study. However, in practice, in the current context of Benin, only MSM known as such are accessible and they represent only a small proportion of all MSM. This study does not consider the most hidden MSM, whose proportion is likely to be high in a context of important stigmatization of MSM, as in many African countries. Beyond these limits, the results obtained could be very useful in the implementation process of PrEP strategy among MSM in Benin.

Conclusion

Not all MSM knew about PrEP in Benin, but, after being informed about it, almost all participants were willing to use PrEP if made available. The free availability of the drug and its accessibility in the MSM networks could facilitate the use of PrEP among MSM in Benin. The implementation of the PrEP strategy will have to consider these factors to ensure its success in Benin. Although some MSM may reduce condom use and increase the number of sexual partners and intercourses if using PrEP, this should not hamper its implementation. When available, prescribers should provide informed support to MSM in choosing their HIV prevention options (condom and / or PrEP).

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Abbreviations

HIV:

Human Immunodeficiency Viruses

MSM:

Men who have Sex with Men

PrEP:

Pre-exposure Prophylaxis

RDS:

Respondent Driven Sampling

WHO:

World Health Organization;

STI:

Sexually Transmitted Infections

LGBT:

Lesbian, Gay, Bisexual, Transgender

References

  1. Hessou PS, Glele-Ahanhanzo Y, Adekpedjou R, Ahouada C, Johnson RC, Boko M, Zomahoun HTV, et al. Comparison of the prevalence rates of HIV infection between men who have sex with men (MSM) and men in the general population in sub-Saharan Africa: a systematic review and meta-analysis. BMC Public Health. 2019;19(1):1634.

    PubMed  PubMed Central  Google Scholar 

  2. Beyrer C, Baral SD, van Griensven F, Goodreau SM, Chariyalertsak S, Wirtz AL, et al. Global epidemiology of HIV infection in men who have sex with men. Lancet. 380(9839):367–77.

  3. Hladik F, McElrath MJ. Setting the stage: host invasion by HIV. Nat Rev Immunol. 2008;8(6):447–57.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Royce RA, Seña A, Cates WJ, Cohen MS. Sexual transmission of HIV. N Engl J Med. 1997;336(15):1072–8.

    CAS  PubMed  Google Scholar 

  5. Plan International Benin: Enquête de Surveillance de Deuxième Génération (ESDG) du VIH et des IST auprès des Hommes ayant des Rapports Sexuels avec les Hommes (HSH) au Bénin. 2014.

    Google Scholar 

  6. UNAIDS: AIDSinfo–UNAIDS. 2019.

    Google Scholar 

  7. Girault P, Green K, Clement NF, Rahman YAA, Adams B, Wambugu S. Piloting a social networks strategy to increase HIV testing and counseling among men who have sex with men in Greater Accra and Ashanti region, Ghana. AIDS Behav. 2015;19(11):1990–2000.

    PubMed  Google Scholar 

  8. JB MG, Anderson S-J, Hallett TB. PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa. J Int AIDS Soc. 2016;19(7S6):21104.

    Google Scholar 

  9. Spinner CD, Boesecke C, Zink A, Jessen H, Stellbrink H-J, Rockstroh JK, et al. HIV pre-exposure prophylaxis (PrEP): a review of current knowledge of oral systemic HIV PrEP in humans. Infection. 2016;44(2):151–8.

    PubMed  Google Scholar 

  10. McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 387(10013):53–60.

  11. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–99.

    CAS  PubMed  PubMed Central  Google Scholar 

  12. Molina J-M, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, et al. On-demand Preexposure prophylaxis in men at high risk for HIV-1 infection. N Engl J Med. 2015;373(23):2237–46.

    CAS  PubMed  Google Scholar 

  13. Koechlin FM, Fonner VA, Dalglish SL, O’Reilly KR, Baggaley R, Grant RM, et al. Values and preferences on the use of oral pre-exposure prophylaxis (PrEP) for HIV prevention among multiple populations: a systematic review of the literature. AIDS Behav. 2017;21(5):1325–35.

    PubMed  Google Scholar 

  14. World Health Organization. Guideline on When to Start Antiretroviral Therapy and on Pre-Exposure Prophylaxis for HIV. Geneva: WHO; 2015. In.; 2016.

    Google Scholar 

  15. Hannaford A, Lipshie-Williams M, Starrels JL, Arnsten JH, Rizzuto J, Cohen P, et al. The use of online posts to identify barriers to and facilitators of HIV pre-exposure prophylaxis (PrEP) among men who have sex with men: a comparison to a systematic review of the peer-reviewed literature. AIDS Behav. 2017:1–16.

  16. Ogunbajo A, Iwuagwu S, Williams R, Biello K, Mimiaga MJ. Awareness, willingness to use, and history of HIV PrEP use among gay, bisexual, and other men who have sex with men in Nigeria. PLoS One. 2019;14(12):e0226384.

  17. Ogunbajo A, Kang A, Shangani S, Wade RM, Onyango DP, Odero WW, et al. Awareness and acceptability of pre-exposure prophylaxis (PrEP) among gay, bisexual and other men who have sex with men (GBMSM) in Kenya. AIDS Care. 2019;31(10):1185–92.

    PubMed  Google Scholar 

  18. Emmanuel G, Folayan M, Undelikwe G, Ochonye B, Jayeoba T, Yusuf A, et al. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria. BMC Public Health. 2020;20(1):69.

    CAS  PubMed  PubMed Central  Google Scholar 

  19. Schonlau M, Liebau E. Respondent-driven sampling. Stata J. 2012;12(1):72–93.

    Google Scholar 

  20. Plan International Benin: Analyse de la situation des HSH et des UDI en matière de lutte contre les IST/VIH/SIDA au Bénin (Estimation des tailles des HSH, UDI et cartographie des sites et lieux de rencontre). 2013.

    Google Scholar 

  21. Ahouada C, Diabaté S, Gning NN, Hessou S, Batona G, Guédou FA, et al. Acceptability of pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in Benin: a qualitative study. AIDS Care. 2020;32(2):242–8.

  22. Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18(2):195–216.

    PubMed  Google Scholar 

  23. Yang D, Chariyalertsak C, Wongthanee A, Kawichai S, Yotruean K. Saokhieo P, and al: acceptability of pre-exposure prophylaxis among men who have sex with men and transgender women in northern Thailand. PLoS One. 2013;8(10):e76650.

    CAS  PubMed  PubMed Central  Google Scholar 

  24. Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDs. 2013;27(4):248–54.

    PubMed  PubMed Central  Google Scholar 

  25. Godin G. Les comportements dans le domaine de la santé: comprendre pour mieux intervenir: Presses de l'Université de Montréal; 2012.

    Google Scholar 

  26. Hosek S, Siberry G, Bell M, Lally M, Kapogiannis B, Green K, Fernandez MI, et al. Project PrEPare (ATN082): The Acceptability and Feasibility of an HIV Pre-Exposure Prophylaxis (PrEP) Trial with Young Men who Have Sex with Men (YMSM). J Acquir Immune Defic Syndr. 2013;62(4). https://doi.org/10.1097/QAI.1090b1013e3182801081.

  27. Jackson T, Huang A, Chen H, Gao X, Zhong X, Zhang Y. Cognitive, psychosocial, and sociodemographic predictors of willingness to use HIV pre-exposure prophylaxis among Chinese men who have sex with men. AIDS Behav. 2012;16(7):1853–61.

    PubMed  Google Scholar 

  28. Perez-Figueroa RE, Kapadia F, Barton SC, Eddy JA, Halkitis PN. Acceptability of PrEP uptake among racially/ethnically diverse Young men who have sex with men: the P18 study. AIDS Educ Prev. 2015;27(2):112–25.

    PubMed  PubMed Central  Google Scholar 

  29. Lauritsen J. EpiData data entry, data management and basic statistical analysis system. Odense Denmark: EpiData Association; 2008.

    Google Scholar 

  30. Mark S. Handcock IEF, Krista J. Gile RDS Analyst: Software for the Analysis of Respondent-Driven Sampling Data, Version 0.65 2016.

  31. Volz E, Heckathorn DD. Probability based estimation theory for respondent driven sampling. J Off Stat. 2008;24(1):79.

    Google Scholar 

  32. Volz E, Wejnert C, Degani I, Heckathorn D. 2007 Respondent-Driven Sampling Analysis Tool (RDSAT) Version 5.6; 2007.

    Google Scholar 

  33. Lachowsky NJ, Lin SY, Hull MW, Cui Z, Sereda P. Jollimore J, and al: pre-exposure prophylaxis awareness among gay and other men who have sex with men in Vancouver, British Columbia, Canada. AIDS Behav. 2016;20(7):1408–22.

    PubMed  PubMed Central  Google Scholar 

  34. Townsend L, Johnston LG, Flisher AJ, Mathews C, Zembe Y. Effectiveness of respondent-driven sampling to recruit high risk heterosexual men who have multiple female sexual partners: differences in HIV prevalence and sexual risk behaviours measured at two time points. AIDS Behav. 2010;14(6):1330–9.

    PubMed  Google Scholar 

  35. Couderc C, Keita BD, Anoma C, Wade AS, Coulibaly A, Ehouman S, et al. Is PrEP needed for MSM in West Africa? HIV incidence in a prospective multicountry cohort. J Acquir Immune Defic Syndr. 2017;75(3):e80–2.

    PubMed  Google Scholar 

  36. Hoagland B, De Boni RB, Moreira RI, Madruga JV, Kallas EG, Goulart SP, et al. Awareness and willingness to use pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women in Brazil. AIDS Behav. 2017;21(5):1278–87.

    PubMed  Google Scholar 

  37. Nalá R, Cummings B, Horth R, Inguane C, Benedetti M, Chissano M, Sathane I, et al. Men who have sex with men in Mozambique: identifying a hidden population at high-risk for HIV. AIDS Behav. 2015;19(2):393–404.

    PubMed  Google Scholar 

  38. Yi S, Tuot S, Mwai GW, Ngin C, Chhim K, Pal K, et al. Awareness and willingness to use HIV pre-exposure prophylaxis among men who have sex with men in low- and middle-income countries: a systematic review and meta-analysis. J Int AIDS Soc. 2017;20(1):21580.

    PubMed  PubMed Central  Google Scholar 

  39. Chakrapani V, Newman PA, Shunmugam M, Mengle S, Varghese J, Nelson R, et al. Acceptability of HIV pre-exposure prophylaxis (PrEP) and implementation challenges among men who have sex with men in India: a qualitative investigation. AIDS Patient Care STDs. 2015;29(10):569–77.

    PubMed  Google Scholar 

  40. Grov C, Whitfield TH, Rendina HJ, Ventuneac A, Parsons JT. Willingness to take PrEP and potential for risk compensation among highly sexually active gay and bisexual men. AIDS Behav. 2015;19(12):2234–44.

    PubMed  PubMed Central  Google Scholar 

  41. Mansergh G, Herbst JH, Mimiaga MJ, Holman J. Preference for condoms, antiretroviral preexposure prophylaxis, or both methods to reduce risk for HIV acquisition among uninfected US black and Latino MSM. J Acquir Immune Defic Syndr. 2015;70(4):e153–5.

    PubMed  Google Scholar 

  42. Strauss BB, Greene GJ, Phillips G, Bhatia R, Madkins K. Parsons JT, and al: exploring patterns of awareness and use of HIV pre-exposure prophylaxis among young men who have sex with men. AIDS Behav. 2017;21(5):1288–98.

    PubMed  PubMed Central  Google Scholar 

  43. Torres TS, De Boni RB, de Vasconcellos MT, Luz PM, Hoagland B, Moreira RI, et al. Awareness of prevention strategies and willingness to use Preexposure prophylaxis in Brazilian men who have sex with men using apps for sexual encounters: online cross-sectional study. JPH. 2018;4(1):e11.

    Google Scholar 

  44. Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O’reilly KR, Koechlin FM, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973.

    PubMed  PubMed Central  Google Scholar 

  45. Gust DA, Soud F, Hardnett FP, Malotte CK, Rose C, Kebaabetswe P, et al. Evaluation of sexual risk behavior among study participants in the TDF2 PrEP study among heterosexual adults in Botswana. J Acquir Immune Defic Syndr. 2016;73(5):556–63.

    PubMed  PubMed Central  Google Scholar 

  46. Mboup A, Béhanzin L, Guédou FA, Geraldo N, Goma-Matsétsé E, Giguère K, et al. Early antiretroviral therapy and daily pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: a prospective observational demonstration study. J Int AIDS Soc. 2018;21(11):e25208.

    PubMed  PubMed Central  Google Scholar 

  47. Larmarange J, Becquet V, Masumbuko J-M, Nouaman M, Plazy M, Danel C, et al. Implementing preexposure prophylaxis among key populations: an opportunity for patient-centered services and management of hepatitis B. AIDS. 2018;32(6):829.

    PubMed  PubMed Central  Google Scholar 

  48. Al-Tayyib AA, Thrun MW, Haukoos JS, Walls NE. Knowledge of pre-exposure prophylaxis (PrEP) for HIV prevention among men who have sex with men in Denver, Colorado. AIDS Behav. 2014;18(3):340–7.

    PubMed  PubMed Central  Google Scholar 

  49. Liu AY, Kittredge PV, Vittinghoff E, Raymond HF, Ahrens K, Matheson T, et al. Limited knowledge and use of HIV post-and pre-exposure prophylaxis among gay and bisexual men. J Acquir Immune Defic Syndr. 2008;47(2):241–7.

    PubMed  Google Scholar 

  50. Mimiaga MJ, Case P, Johnson CV, Safren SA, Mayer KH. Preexposure antiretroviral prophylaxis attitudes in high-risk Boston area men who report having sex with men: limited knowledge and experience but potential for increased utilization after education. J Acquir Immune Defic Syndr. 2009;50(1):77–83.

    PubMed  PubMed Central  Google Scholar 

  51. Rucinski KB, Mensah NP, Sepkowitz KA, Cutler BH, Sweeney MM, Myers JE. Knowledge and use of pre-exposure prophylaxis among an online sample of young men who have sex with men in New York City. AIDS Behav. 2013;17(6):2180–4.

    PubMed  Google Scholar 

  52. Brooks RA, Landovitz RJ, Kaplan RL, Lieber E, Lee SJ, Barkley TW. Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study. AIDS Patient Care STDs. 2012;26(2):87–94.

    PubMed  PubMed Central  Google Scholar 

  53. Haberer JE, Kidoguchi L, Heffron R, Mugo N, Bukusi E, Katabira E, Asiimwe S, Thomas KK, Celum C, Baeten JM. Alignment of adherence and risk for HIV acquisition in a demonstration project of pre-exposure prophylaxis among HIV serodiscordant couples in Kenya and Uganda: a prospective analysis of prevention-effective adherence. J Int AIDS Soc. 2017;20(1):21842.

  54. Marcus JL, Katz KA, Krakower DS, Calabrese SK. Risk compensation and clinical decision making—the Case of HIV Preexposure prophylaxis. N Engl J Med. 2019;380(6):510–2.

    PubMed  PubMed Central  Google Scholar 

  55. Milam J, Jain S, Dubé MP, Daar ES, Sun X, Corado K, Ellorin E, Blumenthal J, Haubrich R, Moore DJ. Sexual risk compensation in a pre-exposure prophylaxis demonstration study among individuals at risk of HIV. J Acquir Immune Defic Syndr. 2019;80(1):e9–e13.

    PubMed  PubMed Central  Google Scholar 

  56. Montaño MA, Dombrowski JC, Dasgupta S, Golden MR, Manhart LE, Barbee LA, Duerr A, Khosropour CM. Differences in STI Risk comparing PrEP users and propensity score-matched historical controls in a clinic setting. AIDS. 2019;33(11):1773–80.

  57. Jenness SM, Weiss KM, Goodreau SM, Gift T, Chesson H, Hoover KW, Smith DK, Liu AY, Sullivan PS, Rosenberg ES. Incidence of gonorrhea and chlamydia following human immunodeficiency virus preexposure prophylaxis among men who have sex with men: a modeling study. Clin Infect Dis. 2017;65(5):712–8.

    PubMed  PubMed Central  Google Scholar 

  58. Aghaizu A, Mercey D, Copas A, Johnson AM, Hart G, Nardone A. Who would use PrEP? Factors associated with intention to use among MSM in London: a community survey. Sex Transm Infect. 2013;89(3):207–11.

    PubMed  Google Scholar 

  59. Barash EA, Golden M. Awareness and use of HIV pre-exposure prophylaxis among attendees of a Seattle gay pride event and sexually transmitted disease clinic. AIDS Patient Care STDs. 2010;24(11):689–91.

    PubMed  Google Scholar 

  60. Young I, Li J, McDaid L. Awareness and willingness to use HIV pre-exposure prophylaxis amongst gay and bisexual men in Scotland: implications for biomedical HIV prevention. PLoS One. 2013;8(5):e64038.

    CAS  PubMed  PubMed Central  Google Scholar 

  61. Holt M, Murphy DA, Callander D, Ellard J, Rosengarten M, Kippax SC, de Wit JB. Willingness to use HIV pre-exposure prophylaxis and the likelihood of decreased condom use are both associated with unprotected anal intercourse and the perceived likelihood of becoming HIV positive among Australian gay and bisexual men. Sex Transm Infect. 2012;88(4):258–63.

    PubMed  Google Scholar 

  62. Leonardi M, Lee E, Tan DH. Awareness of, usage of and willingness to use HIV pre-exposure prophylaxis among men in downtown Toronto, Canada. Int J STD AIDS. 2011;22(12):738–41.

    CAS  PubMed  Google Scholar 

  63. Zhou F, Gao L, Li S, Li D, Zhang L, Fan W, Yang X, Yu M, Xiao D, Yan L, et al. Willingness to accept HIV pre-exposure prophylaxis among Chinese men who have sex with men. PLoS One. 2012;7(3):e32329.

    CAS  PubMed  PubMed Central  Google Scholar 

  64. Golub SA, Kowalczyk W, Weinberger CL, Parsons JT. Preexposure prophylaxis and predicted condom use among high-risk men who have sex with men. J Acquir Immune Defic Syndr (1999). 2010;54(5):548.

    Google Scholar 

  65. Plan International Benin: Enquête de Surveillance de Deuxième Génération (ESDG) du VIH et des IST auprès des Hommes ayant des Rapports Sexuels avec les Hommes (HSH) au Bénin. 2017.

  66. Coulaud PJ, Sagaon-Teyssier L, M'Madi Mrenda B, Maradan G, Mora M, Bourrelly M, Dembele Keita B, Keita AA, Anoma C, Babo Yoro SA, et al. Interest in HIV pre-exposure prophylaxis in men who have sex with men in West Africa (CohMSM ANRS 12324 - expertise France). Tropical Med Int Health. 2018;23(10):1084–91.

    Google Scholar 

Download references

Acknowledgments

We would like to thank all the participants, the interviewers and especially the representatives of all Beninese MSM associations for their involvement.

Funding

This study was funded by the Canadian Institutes of Health Research (grant # FDN-143218).

Author information

Authors and Affiliations

  1. Hopital de Zone Allada, Allada, Benin

    Carin Ahouada

  2. Centre de recherche du CHU de Québec, Université Laval, Québec, Québec, Canada

    Carin Ahouada, Souleymane Diabaté, Myrto Mondor, Ndeye Ndiagna Gning & Michel Alary

  3. Département de médecine sociale et préventive, Université Laval, Québec, Québec, Canada

    Carin Ahouada, Souleymane Diabaté, Ndeye Ndiagna Gning & Michel Alary

  4. Université Alassane Ouattara, Bouaké, Côte d’Ivoire

    Souleymane Diabaté

  5. Centre Interfacultaire de Formation et de Recherche en Environnement pour le Développement Durable (CIFRED/UAC), Abomey-Calavi, Bénin

    Septime Hessou

  6. Dispensaire des IST, Centre de Santé Cotonou I, Cotonou, Bénin

    Fernand A. Guédou, Luc Béhanzin & Georges Batona

  7. École Nationale de Formation des Techniciens Supérieurs en Santé Publique et en Surveillance Épidémiologique, Université de Parakou, Parakou, Bénin

    Luc Béhanzin

  8. Centre National Hospitalier et Universitaire Hubert Koutoukou Maga de Cotonou, Cotonou, Benin

    D. Marcel Zannou

  9. Faculté des Sciences de la Santé, Cotonou, Bénin

    D. Marcel Zannou

  10. Institut national de santé publique, Québec, Québec, Canada

    Michel Alary

  11. Hôpital du Saint-Sacrement 1050 chemin Ste-Foy Québec, Québec, QC, G1S 4L8, Canada

    Michel Alary

Authors
  1. Carin Ahouada
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Souleymane Diabaté
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Myrto Mondor
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Septime Hessou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Fernand A. Guédou
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Luc Béhanzin
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Georges Batona
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ndeye Ndiagna Gning
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. D. Marcel Zannou
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Michel Alary
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

CA, SD and MA conceptualized the study. SH contributed to the choice of the data collection technique and precautions to be taken. CA, SH, FG, LB and GB were responsible for data acquisition. CA, MM and MA carried out the statistical analyses. NNG, DMZ and all other authors interpreted the data and substantively revised the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Michel Alary.

Ethics declarations

Ethics approval and consent to participate

The national ethics committee of Benin and the ethics committee of the CHU de Québec – Université Laval, Quebec, Canada approved this study. A written informed consent was obtained from each participant. A financial compensation of 2,000 F CFA (approximately US $ 4) was granted to each participant to compensate for the time he spent for the study and his travel expenses.

Consent for publication

Not applicable.

Competing interests

MA reports funding from the Canadian Institutes of Health Research (CIHR, grant # FDN-143218) that was used to support this study. MA also reports other funding from CIHR, the Bill & Melinda Gates Foundation, the Fonds de la recherche du Québec – Santé and the Public Health Agency of Canada unrelated to the present study. The other authors do not have any competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ahouada, C., Diabaté, S., Mondor, M. et al. Acceptability of pre-exposure prophylaxis for HIV prevention: facilitators, barriers and impact on sexual risk behaviors among men who have sex with men in Benin. BMC Public Health 20, 1267 (2020). https://doi.org/10.1186/s12889-020-09363-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-020-09363-4

Keywords

BMC Public Health

ISSN: 1471-2458

Contact us